A Blood Tests Panel screening for future studies in HV & patients
Research type
Research Study
Full title
Recruiting and screening healthy male and female volunteers and patient groups, to a blood tests panel, for consideration in future clinical research studies
IRAS ID
302984
Contact name
Pablo ForteSoto
Contact email
Sponsor organisation
Parexel International
Duration of Study in the UK
14 years, 4 months, 17 days
Research summary
The screening protocol will allow Parexel to recruit and screen healthy volunteers and patients with different blood test results to build a suitable Bloods test panel for forthcoming clinical studies. Those suitable will be invited to attend study specific screening only when both ethical and regulatory approvals have been granted. Before these subjects are screened for the Bloods test panel, they will be fully informed and will give written consent. All subjects will be recruited and screened in accordance with Parexel standard operating procedures (SOPs) and the International Conference on Harmonisation (ICH) Guideline on Good Clinical Practice (GCP).
The bloods test panel screening procedures will usually consist of Blood Tests, Date of Birth (DOB) Race, History of Medications, Height and Weight all of which are used in the majority of studies in order to evaluate suitability for enrolment. Any subjects that are deemed suitable for inclusion in this bloods test panel will be asked to provide details of their General Practitioner (GP), so that written notification of their potential participation in a clinical study can be sent along with a questionnaire to obtain a medical history. Subjects will be confirmed suitable based on the bloods test panel screening procedures.
REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
21/NW/0249
Date of REC Opinion
4 Nov 2021
REC opinion
Further Information Favourable Opinion